Minireviews
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. Oct 16, 2012; 4(10): 462-471
Published online Oct 16, 2012. doi: 10.4253/wjge.v4.i10.462
Ultra high magnification endoscopy: Is seeing really believing?
Aman V Arya, Brian M Yan
Aman V Arya, Brian M Yan, Division of Gastroenterology, Department of Medicine, Western University, London, ON N6G 5W9 Ontario, Canada
Author contributions: Arya AV and Yan BM contributed to this paper.
Correspondence to: Brian M Yan, MD, FRCPC, Division of Gastroenterology, Department of Medicine, Western University, Rm E1-419A, LHSC Victoria Campus, 800 Commissioners Road East, London, ON N6G 5W9 Ontario, Canada. brian.yan@lhsc.on.ca
Telephone: +1-519-6858500-77636 Fax: +1-519-6676820
Received: August 30, 2011
Revised: May 29, 2012
Accepted: October 10, 2012
Published online: October 16, 2012
Abstract

Endoscopy is an indispensible diagnostic and therapeutic instrument for gastrointestinal diseases. Endocytoscopy and confocal endomicroscopy are two types of ultra high magnification endoscopy techniques. Standard endoscopy allows for 50 × magnification, whereas endocytoscopy can magnify up to 1400 × and confocal endomicroscopy can magnify up to 1000 ×. These methods open the realm of real time microscopic evaluation of the GI tract, including cellular and subcellular structures. Confocal endomicroscopy has the additional advantage of being able to visualize subsurface structures. The use of high magnification endoscopy in conjunction with standard endoscopy allows for a real-time microscopic assessment of areas with macroscopic abnormalities, providing “virtual biopsies” with valuable information about cellular and subcellular changes. This can minimize the number of biopsies taken at the time of endoscopy. The use of this technology may assist in detecting pre-malignant or malignant changes at an earlier state, allowing for earlier intervention and treatment. High magnification endoscopy has shown promising results in clinical trials for Barrett’s esophagus, esophageal adenocarcinoma, esophageal squamous cell cancer, gastric cancer, celiac disease, colorectal cancer, and inflammatory bowel disease. As the use of high magnification endoscopy techniques increases, the clinical applications will increase as well. Of the two systems, only confocal endomicroscopy is currently commercially available. Like all new technologies there will be an initial learning curve before operators become proficient in obtaining high quality images and discerning abnormal from normal pathology. Validated criteria for the diagnosis of the various gastrointestinal diseases will need to be developed for each method. In this review, the basic principles of both modalities are discussed, along with their clinical applicability and limitations.

Keywords: Endocytoscopy; Confocal endomicroscopy; Confocal laser endomicroscopy; High magnification endoscopy